Evidence map›Paper›PMID 28436637›Full record

ReviewZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences2017

[Research progress on mechanism of Nix-mediated mitophagy].

Yanrong Zheng, Xiangnan Zhang, Zhong Chen

Open access · greenAbstract readReview
In one paragraph

Review in Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. The Role of Mitophagy in Regulating Cell Death.Oxidative medicine and cellular longevity · 2021
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yanrong ZhengCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
Xiangnan ZhangCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
Zhong ChenCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. chenzhong@zju.edu.cn.
Zhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autophagy is fundamental to maintain cellular homeostasis. As one kind of the most well-studied selective autophagy, autophagy of mitochondria (mitophagy)is crucial for the clearance of damaged mitochondria. Mitophagy dysfunction has been proved to be closely associated with many human diseases. Nix is a key protein for mitophagy during the maturation of reticulocytes. However, the detailed molecular mechanisms underlying Nix-mediated mitophagy are not fully understood. This article summarizes three possible working models of Nix in mitophagy induction. Firstly, Nix can interplay with Parkin, another important protein for mitophagy, to initiate mitophagy. Secondly, Nix can serve as a receptor for autophagy machinery by interacting with Atg8 family through its LIR motif. Finally, as a BH3-only protein, Nix can compete with Beclin-1 to bind other members of Bcl-2 family resulting in increased free Beclin-1 in cytosol, which further promotes autophagy flux.

Indexed as

AutophagyAutophagy-Related Protein 8 FamilyBeclin-1Membrane ProteinsMitochondriaMitophagyProtein Interaction Domains and MotifsProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2Tumor Suppressor ProteinsUbiquitin-Protein LigasesAutophagy-Related Protein 8 FamilyBeclin-1BNIP3L protein, humanMembrane Proteinsparkin proteinProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2Tumor Suppressor ProteinsUbiquitin-Protein Ligases

Identifiers

PMID28436637
PMCPMC10396831
OpenAlexW2741510057

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.